sc 58125 has been researched along with Cell Transformation, Neoplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albo, D; Beauchamp, RD; Berger, DH; DuBois, RN; O'Mahony, CA; Shao, J; Sheng, H | 1 |
| Beauchamp, RD; Coffey, RJ; DuBois, RN; Hooton, EB; Isakson, PC; Morrow, JD; Shao, J; Sheng, GG; Sheng, H | 1 |
2 other study(ies) available for sc 58125 and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions.
Topics: Animals; Cell Adhesion; Cell Line; Cell Line, Transformed; Cell Transformation, Neoplastic; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Extracellular Matrix; Fibrinolysin; Intestinal Mucosa; Isoenzymes; Neoplasm Invasiveness; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Transforming Growth Factor beta; Transforming Growth Factor beta1; Urokinase-Type Plasminogen Activator | 2003 |
A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells.
Topics: Animals; Apoptosis; Carcinogenicity Tests; Cell Division; Cell Transformation, Neoplastic; Collagen; Cyclooxygenase 2; DNA; Drug Combinations; Enzyme Inhibitors; Genes, ras; Intestinal Mucosa; Intestinal Neoplasms; Isoenzymes; Laminin; Mice; Mice, Nude; Prostaglandin-Endoperoxide Synthases; Proteoglycans; Pyrazoles; Rats | 1997 |